Literature DB >> 21149600

An intact canonical NF-κB pathway is required for inflammatory gene expression in response to hypoxia.

Susan F Fitzpatrick1, Murtaza M Tambuwala, Ulrike Bruning, Bettina Schaible, Carsten C Scholz, Annette Byrne, Aisling O'Connor, William M Gallagher, Colin R Lenihan, John F Garvey, Katherine Howell, Padraic G Fallon, Eoin P Cummins, Cormac T Taylor.   

Abstract

Hypoxia is a feature of the microenvironment in a number of chronic inflammatory conditions due to increased metabolic activity and disrupted perfusion at the inflamed site. Hypoxia contributes to inflammation through the regulation of gene expression via key oxygen-sensitive transcriptional regulators including the hypoxia-inducible factor (HIF) and NF-κB. Recent studies have revealed a high degree of interdependence between HIF and NF-κB signaling; however, the relative contribution of each to hypoxia-induced inflammatory gene expression remains unclear. In this study, we use transgenic mice expressing luciferase under the control of NF-κB to demonstrate that hypoxia activates NF-κB in the heart and lungs of mice in vivo. Using small interfering RNA targeted to the p65 subunit of NF-κB, we confirm a unidirectional dependence of hypoxic HIF-1α accumulation upon an intact canonical NF-κB pathway in cultured cells. Cyclooxygenase-2 and other key proinflammatory genes are transcriptionally induced by hypoxia in a manner that is both HIF-1 and NF-κB dependent, and in mouse embryonic fibroblasts lacking an intact canonical NF-κB pathway, there is a loss of hypoxia-induced inflammatory gene expression. Finally, under conditions of hypoxia, HIF-1α and the p65 subunit of NF-κB directly bind to the cyclooxygenase-2 promoter. These results implicate an essential role for NF-κB signaling in inflammatory gene expression in response to hypoxia both through the regulation of HIF-1 and through direct effects upon target gene expression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21149600     DOI: 10.4049/jimmunol.1002256

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  62 in total

Review 1.  HIF transcription factors, inflammation, and immunity.

Authors:  Asis Palazon; Ananda W Goldrath; Victor Nizet; Randall S Johnson
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

2.  NFκB and HIF display synergistic behaviour during hypoxic inflammation.

Authors:  Ulrike Bruning; Susan F Fitzpatrick; Till Frank; Marc Birtwistle; Cormac T Taylor; Alex Cheong
Journal:  Cell Mol Life Sci       Date:  2011-11-09       Impact factor: 9.261

3.  Transcription regulates HIF-1α expression in CD4(+) T cells.

Authors:  Thomas Bollinger; Annalena Bollinger; Sydney Gies; Lea Feldhoff; Werner Solbach; Jan Rupp
Journal:  Immunol Cell Biol       Date:  2015-07-07       Impact factor: 5.126

4.  Pulmonary surfactant-associated proteins and inflammatory factors in obstructive sleep apnea.

Authors:  Dongmei Lu; Ayiniger Abulimiti; Ting Wu; Ailigen Abudureyim; Nanfang Li
Journal:  Sleep Breath       Date:  2017-07-13       Impact factor: 2.816

Review 5.  Emerging co-morbidities of obstructive sleep apnea: cognition, kidney disease, and cancer.

Authors:  Nadia Gildeh; Panagis Drakatos; Sean Higgins; Ivana Rosenzweig; Brian D Kent
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

6.  Graviola: a novel promising natural-derived drug that inhibits tumorigenicity and metastasis of pancreatic cancer cells in vitro and in vivo through altering cell metabolism.

Authors:  María P Torres; Satyanarayana Rachagani; Vinee Purohit; Poomy Pandey; Suhasini Joshi; Erik D Moore; Sonny L Johansson; Pankaj K Singh; Apar K Ganti; Surinder K Batra
Journal:  Cancer Lett       Date:  2012-04-01       Impact factor: 8.679

Review 7.  HIF1α and metabolic reprogramming in inflammation.

Authors:  Sarah E Corcoran; Luke A J O'Neill
Journal:  J Clin Invest       Date:  2016-08-29       Impact factor: 14.808

8.  Potential inflammatory markers in obstructive sleep apnea-hypopnea syndrome.

Authors:  Dongmei Lu; Nanfang Li; Xiaoguang Yao; Ling Zhou
Journal:  Bosn J Basic Med Sci       Date:  2017-02-21       Impact factor: 3.363

Review 9.  Intestinal hypoxia and hypoxia-induced signalling as therapeutic targets for IBD.

Authors:  Sophie Van Welden; Andrew C Selfridge; Pieter Hindryckx
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-08-30       Impact factor: 46.802

Review 10.  Redox control of inflammation in macrophages.

Authors:  Bernhard Brüne; Nathalie Dehne; Nina Grossmann; Michaela Jung; Dmitry Namgaladze; Tobias Schmid; Andreas von Knethen; Andreas Weigert
Journal:  Antioxid Redox Signal       Date:  2013-03-06       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.